Founded in 1833, McKesson Corporation operates as a pharmaceutical and medical supply distributor serving healthcare providers, pharmacies, and life sciences companies across the United States and internationally. The company's primary business involves distributing branded, generic, specialty, and biosimilar pharmaceutical drugs alongside healthcare-related products and services. Beyond distribution, McKesson provides practice management solutions, technology platforms, clinical support, and business consulting services targeting community-based oncology practices and other specialty healthcare providers.
The company operates through four main segments. The U.S. Pharmaceutical segment handles drug distribution and provides technology and operational solutions to pharmacies and specialty practices. The Prescription Technology Solutions segment connects patients, pharmacies, providers, and pharmaceutical companies through medication access platforms, prior authorization services, and pricing transparency tools. The Medical-Surgical Solutions segment distributes medical supplies and provides logistics and maintenance services to physician offices, surgery centers, nursing homes, and post-acute care facilities. The International segment delivers medicines, supplies, and technology solutions to pharmacies, hospitals, and clinics outside the United States.
With approximately 43,000 full-time employees, McKesson operates at substantial scale as a major healthcare infrastructure provider. The company is headquartered in Irving, Texas, and is incorporated in Delaware.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $25.72 | $25.86 | +14.9% | |
| 2024 | $22.39 | $22.54 | -10.5% | |
| 2023 | $25.03 | $25.23 | +246.2% | |
| 2022 | $7.23 | $7.32 | +74.2% | |
| 2021 | $4.15 | $4.19 | -29.1% | |
| 2020 | $5.85 | $5.89 | +240.3% | |
| 2019 | $-4.17 | $-4.17 | +25.3% | |
| 2018 | $-5.58 | $-5.58 | -133.3% | |
| 2017 | $16.76 | $16.92 | +791.5% | |
| 2016 | $1.88 | $1.90 | +235.7% | |
| 2015 | $0.56 | $0.57 | -64.6% | |
| 2013 | $1.58 | $1.61 | +43.6% | |
| 2012 | $1.10 | $1.12 | -47.4% | |
| 2011 | $2.09 | $2.14 | +29.0% | |
| 2010 | $1.62 | $1.65 | -64.9% | |
| 2009 | $4.62 | $4.70 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-03-31 | 2025-05-09 | 0000927653-25-000036 | SEC ↗ |
| 2024-03-31 | 2024-05-08 | 0000927653-24-000035 | SEC ↗ |
| 2023-03-31 | 2023-05-09 | 0000927653-23-000038 | SEC ↗ |
| 2022-03-31 | 2022-05-09 | 0000927653-22-000051 | SEC ↗ |
| 2021-03-31 | 2021-05-12 | 0000927653-21-000039 | SEC ↗ |
| 2020-03-31 | 2020-05-22 | 0000927653-20-000033 | SEC ↗ |
| 2019-03-31 | 2019-05-15 | 0000927653-19-000009 | SEC ↗ |
| 2018-03-31 | 2018-05-24 | 0000927653-18-000010 | SEC ↗ |
| 2017-03-31 | 2017-05-22 | 0000927653-17-000007 | SEC ↗ |
| 2016-03-31 | 2016-05-05 | 0000927653-16-000020 | SEC ↗ |
| 2015-03-31 | 2015-05-12 | 0001628280-15-004098 | SEC ↗ |